• Thumbnail for Sirolimus
    Sirolimus blocks this pathway. The safety and efficacy of sirolimus treatment of LAM were investigated in clinical trials that compared sirolimus treatment...
    69 KB (6,838 words) - 09:56, 30 July 2024
  • Thumbnail for Lymphangioma
    systemic medication, or through observation. Sirolimus is used to treat lymphangioma. Treatment with sirolimus can decrease pain and the fullness of venous...
    21 KB (2,399 words) - 07:31, 9 April 2024
  • Thumbnail for Immunosuppressive drug
    Everolimus is an analog of sirolimus and also is an mTOR inhibitor. Zotarolimus is a semi-synthetic derivative of sirolimus used in drug-eluting stents...
    29 KB (3,337 words) - 00:02, 9 August 2024
  • Thumbnail for Everolimus
    needed] It is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR)...
    27 KB (2,534 words) - 22:53, 12 July 2024
  • Thumbnail for MTOR inhibitors
    sites for mTOR and FKBP12. The bacterial natural product rapamycin or sirolimus, a cytostatic agent, has been used in combination therapy with corticosteroids...
    57 KB (6,278 words) - 05:05, 3 June 2024
  • Thumbnail for Hives
    medications (dapsone, sulfasalazine), immunosuppressants (cyclosporin, sirolimus) or other medications like omalizumab can be used. These options are explained...
    50 KB (5,739 words) - 13:46, 6 August 2024
  • Thumbnail for Methylprednisolone
    triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813 Suberoylanilide Sulfisoxazole Suramin...
    57 KB (5,140 words) - 21:09, 11 July 2024
  • Thumbnail for Neurofibroma
    Sirolimus, a compound that inhibits mTOR signalling, is being studied to treat plexiform neurofibromas. The combination of erlotinib with sirolimus was...
    30 KB (3,257 words) - 07:19, 4 August 2024
  • Thumbnail for Lymphangioleiomyomatosis
    (mTORC1) led to successful use of rapamycin analog sirolimus in clinical trials and FDA approval of sirolimus for treatment of LAM. TSC1 and TSC2 form a tumor...
    100 KB (11,094 words) - 11:12, 6 March 2024
  • Thumbnail for Tacrolimus
    hypomagnesemia, hyperglycemia, diabetes mellitus, itching, lung damage (sirolimus also causes lung damage), and various neuropsychiatric problems such as...
    43 KB (4,357 words) - 08:11, 15 July 2024